Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
Prostate cancer researcher Dr. Janet Stanford retires after three decades
Career of discoveries about prostate cancer genetics, risks, outcomes
DNA methylation: a link between physical activity and reduced prostate cancer progression?
From the Dai, Stanford, and Wright Groups, Public Health Sciences Division
An upgrade in prostate cancer prognosis predictions
From the Stanford Group, Public Health Sciences Division
Parsing the deadliness of prostate cancer
Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Fred Hutch receives $11.3M NCI grant renewal to lead Pacific Northwest prostate cancer research consortium - Fred Hutchinson Cancer Research Center
Third consecutive five-year Prostate Cancer SPORE grant brings total NCI funding to $35.8M
Mutations in a gene that impacts immune function increase susceptibility to prostate cancer - Fred Hutchinson Cancer Research Center
Research has implications for risk of both hereditary and sporadic disease
Coffee may keep prostate cancer recurrence and progression away - Fred Hutchinson Cancer Research Center
Bioactive compounds in coffee may have anti-inflammatory and antioxidant effects
Fred Hutchinson Cancer Research Center study shows statins may reduce risk of prostate cancer death
Janet Stanford and colleagues find mortality rate among those who use the cholesterol-lowering drugs is 1 percent compared to 5 percent among nonusers
Cholesterol-lowering drugs may reduce risk of dying from prostate cancer - Fred Hutchinson Cancer Research Center
Men who take statins are less likely to die from prostate cancer than those who don’t
Free 'Breakthroughs In Prostate Cancer Research' symposium March 16
Institute for Prostate Cancer Research event features Fred Hutchinson Cancer Research Center scientists discussing advances in genetically tailored treatment for prostate cancer; register by March 9
Fred Hutch study associates deep-fried foods with increased prostate cancer risk
Dr. Janet Stanford and Fred Hutchinson Cancer Research Center colleagues find regular consumption had strongest effect, linked to more aggressive disease
Eating deep-fried foods associated with prostate cancer - Fred Hutchinson Cancer Research Center
Frequent, regular consumption has strongest effect and is linked to more aggressive disease
More than 1.1 million moustaches help fund prostate cancer research
Movember awards $380,000 to Fred Hutchinson Cancer Research Center’s Janet Stanford for work toward a clinical tool to guide treatment, improve survival rates
Prostate biomarker discovery could lead to simple test for lethal cancer
Janet Stanford leads first population-based study to identify and validate five inherited genetic variants strongly associated with prostate cancer progression and mortality
Researchers discover five inherited genetic variants that could help identify the most lethal prostate cancers
From Seattle to Sweden: first population-based study to demonstrate that inherited genetic variants play a role in prostate cancer progression and mortality
Experiencing a real life of science at 16
Changes to Center's minor work permit allows high-school students to perform 'real lab duties'
Hutch Plays Key Role in Largest-Ever Prostate-Cancer Prevention Study; Vitamin E, Selenium to be Tested
Local sites include Northwest Prostate Institute, Puget Sound Cancer Centers, Swedish Cancer Institute, VA Puget Sound Health Care System and Virginia Mason Medical Center